EU Cosmetics Responsible Person and Product Information File

A practical orientation to the Responsible Person (RP) role and the Product Information File (PIF) under the EU Cosmetic Products Regulation — who can act as RP, what the PIF must contain, the Cosmetic Product Safety Report (CPSR), and the options for Japan-origin brands without an EU entity.

At a glance

Statutory basisArticles 4 and 11 of Regulation (EC) 1223/2009.
Who can be the RPA natural or legal person established within the EU and designated in writing for each cosmetic product placed on the market.
What the PIF must containProduct description, CPSR, method of manufacture (GMP statement), evidence of effect (where applicable), and data on animal testing.
Where the PIF is keptAt the address of the RP indicated on the label, in a format easily accessible to the competent authority of the member state where the file is kept.
Retention period10 years from the date the last batch of the product was placed on the market.
Penalties for non-complianceSet by national law; sanctions vary by member state but include market withdrawal, fines, and (in serious cases) criminal liability.

What the RP actually does

The RP is the entity legally accountable for the cosmetic product in the EU market. The role is operational rather than nominal — a brand cannot simply appoint an RP for compliance theatre and then leave the file unmaintained. Specifically, the RP must:

  • Ensure compliance of the cosmetic product with the obligations under the Cosmetic Products Regulation, including ingredient restrictions (Annexes II to VI) and labelling rules.
  • Maintain the PIF and make it available to the competent authority on request, within a reasonable period.
  • Notify the product to the Cosmetic Products Notification Portal (CPNP) before placing it on the market.
  • Take immediate corrective action, including withdrawal or recall, if the product presents a risk to human health, and inform the competent authorities of the member states where the product is made available.
  • Maintain records of serious undesirable effects (SUEs) and notify them to competent authorities through the EU SUE notification portal.
  • Cooperate with competent authorities at all stages of the product's presence on the market.

Three routes to having an RP for a Japan-origin product

1. Appoint an EU-based RP service provider

Specialist regulatory firms in the EU offer RP services, typically priced per SKU and per year. The provider acts as the named RP on the label, holds the PIF, and is the point of contact for competent authorities. Practical points:

  • Provider must be established in the EU and named on the product label with its physical address. A virtual office address is not acceptable in most member states.
  • Liability profile of the provider matters — confirm professional indemnity insurance and the contractual scope of their compliance obligations versus the brand's.
  • The CPSR (safety assessment) must be commissioned through a qualified safety assessor with documented credentials. Some RP providers include CPSR in the service; others charge separately.

2. Use an EU-domiciled distributor that has RP capability

Many established EU cosmetic distributors offer RP services to the brands they distribute. The arrangement aligns the distributor's commercial interest with regulatory responsibility, but ties the brand's regulatory relationship to the distributor — changing distributors typically means changing RP and updating the label.

3. Establish an EU subsidiary as the RP

Suitable for brands with material EU revenue, multi-market operations, or strategic reasons to own the regulatory relationship. Requires an EU-domiciled company, a competent safety assessor either in-house or contracted, and the operational infrastructure to maintain the PIF and respond to authorities. Maximum control; highest ongoing cost.

What the Product Information File contains

Article 11 of the Regulation sets the minimum content. The PIF must include:

A. Product description

A description sufficient to allow the PIF to be clearly attributed to the product. Includes the product name, the responsible manufacturer (the Japanese OEM factory), the batch numbering system, and the trade dress.

B. Cosmetic Product Safety Report (CPSR)

The CPSR is two parts, defined in Annex I:

  • Part A — Cosmetic Product Safety Information.Quantitative and qualitative composition, physical/chemical characteristics and stability of the substances and the cosmetic product, microbiological quality, impurities, trace elements, packaging information, normal and reasonably foreseeable use, exposure to the cosmetic product, exposure to substances, toxicological profile of substances, undesirable effects and serious undesirable effects, and information on the cosmetic product.
  • Part B — Cosmetic Product Safety Assessment.The qualified safety assessor's conclusion, warnings and instructions for use, reasoning, and the assessor's credentials. The assessor must hold a recognised qualification (pharmacy, toxicology, dermatology, medicine, or a similar discipline) and be independent enough to give an objective assessment.

C. Description of the method of manufacture and GMP statement

Description of the method by which the cosmetic product is manufactured, and a statement of compliance with Good Manufacturing Practice (EN ISO 22716 is the harmonised standard). The Japanese OEM factory's GMP certificate scoped to the product family forms the basis; the RP's file reflects this.

D. Proof of the claimed effect

Where the nature of the effect or product justifies it, proof of the claimed effect — e.g., consumer perception studies, instrumental measurements, or peer-reviewed publications supporting a specific claim. Required only for claims that go beyond general cosmetic effect.

E. Data on animal testing

Data on any animal testing performed by the manufacturer, its agents, or suppliers, relating to the development or safety assessment of the cosmetic product or its ingredients, including any such testing carried out to meet legislative or regulatory requirements of non-EU countries.

Common gaps overseas brands hit

  • CPSR commissioned too late. Safety assessment takes 4–8 weeks once stability and toxicology data are available. Commission it in parallel with first production, not after.
  • Japanese GMP certificate not aligned with EU expectations. ISO 22716 alignment of the Japanese OEM factory is the cleanest path. Internal Japanese GMP arrangements without ISO 22716 certification require additional documentation work for the PIF.
  • Ingredient name mismatches. EU expects INCI names exactly. Japanese ingredient name conventions sometimes differ; confirm with the Japanese OEM that the INCI list matches the formulation.
  • Animal testing data gaps. The brand must disclose any animal testing carried out for non-EU regulatory requirements. China registration historically required animal testing for some imported cosmetics — even if not currently required, the PIF must record past testing.

Where to get professional help

Destination-market import requirements are typically handled by customs brokers, regulatory consultants, and law firms admitted in the destination jurisdiction. The site operator is not licensed to provide such advice and does not recommend specific providers; the directory below lists firms that have publicly stated they work with overseas clients in English.

Sources and official references

Primary sources are listed below. Official Japanese-government and destination-market authority pages are preferred. Where only Japanese sources are available, an English translation is paraphrased in the body text and the original Japanese URL is included for verification.

  1. Regulation (EC) 1223/2009 on cosmetic products — consolidated textEUR-Lex
  2. Cosmetic Product Safety Report (CPSR) guidance — European CommissionEuropean Commission
  3. Cosmetic Products Notification Portal (CPNP)European Commission
  4. EN ISO 22716 — Cosmetics, Good Manufacturing Practices (GMP)ISO / CEN

Disclaimer

This article is provided for general informational purposes only. It does not constitute legal, regulatory, customs, tax, or professional advice. Regulations, fees, processing times, and authority practices change without notice and may differ depending on product characteristics, intended use, and the jurisdictions involved.

The site operator is not a licensed Japanese gyōseishoshi (行政書士), attorney, customs broker, patent attorney, or tax accountant, and is not authorized to provide regulated professional services in any jurisdiction. The article references publicly available primary sources and paraphrases them in English for orientation; for any specific matter, consult qualified professionals admitted in the relevant jurisdiction before taking action.

References to third-party companies, products, certifications, or services are factual and do not constitute endorsement, sponsorship, or affiliation.

Last updated: 2026-05-30

Next scheduled review: 2026-11-30